Neogen Corporation Logo

Neogen Corporation

NEOG

(1.8)
Stock Price

17,53 USD

1.31% ROA

0.38% ROE

337165.27x PER

Market Cap.

3.969.306.850,00 USD

28.5% DER

0% Yield

1.28% NPM

Neogen Corporation Stock Analysis

Neogen Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Neogen Corporation Fundamental Stock Analysis
# Analysis Rating
1 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

2 DER

The stock has a minimal amount of debt (28%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

4 PBV

The stock's PBV ratio (1.11x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

6 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

7 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

8 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

9 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-183) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

10 ROE

The stock's ROE indicates a negative return (-0.85%) on shareholders' equity, suggesting poor financial performance.

11 ROA

The stock's ROA (-3.18%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

Neogen Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Neogen Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Neogen Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Neogen Corporation Revenue
Year Revenue Growth
1988 4.800.000
1989 6.200.000 22.58%
1990 6.000.000 -3.33%
1991 6.000.000 0%
1992 6.600.000 9.09%
1993 7.600.000 13.16%
1994 10.700.000 28.97%
1995 11.700.000 8.55%
1996 12.500.000 6.4%
1997 15.300.000 18.3%
1998 18.500.000 17.3%
1999 22.200.000 16.67%
2000 23.512.000 5.58%
2001 34.895.000 32.62%
2002 41.097.000 15.09%
2003 46.488.000 11.6%
2004 55.498.000 16.23%
2005 62.756.000 11.57%
2006 72.433.000 13.36%
2007 86.138.000 15.91%
2008 102.418.000 15.9%
2009 118.721.000 13.73%
2010 140.509.000 15.51%
2011 172.683.000 18.63%
2012 184.046.000 6.17%
2013 207.528.000 11.32%
2014 247.405.000 16.12%
2015 283.074.000 12.6%
2016 321.275.000 11.89%
2017 361.594.000 11.15%
2018 402.252.000 10.11%
2019 414.186.000 2.88%
2020 418.170.000 0.95%
2021 468.459.000 10.73%
2022 527.159.000 11.14%
2023 822.447.000 35.9%
2024 915.948.000 10.21%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Neogen Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 1.200.000 100%
1997 1.300.000 7.69%
1998 1.400.000 7.14%
1999 1.600.000 12.5%
2000 1.600.000 0%
2001 1.838.000 12.95%
2002 2.252.000 18.38%
2003 2.914.000 22.72%
2004 2.893.000 -0.73%
2005 2.729.000 -6.01%
2006 2.988.000 8.67%
2007 3.295.000 9.32%
2008 3.639.000 9.45%
2009 4.555.000 20.11%
2010 6.258.000 27.21%
2011 6.825.000 8.31%
2012 6.636.000 -2.85%
2013 7.781.000 14.72%
2014 8.326.000 6.55%
2015 9.577.000 13.06%
2016 9.890.000 3.16%
2017 10.385.000 4.77%
2018 10.855.000 4.33%
2019 12.805.000 15.23%
2020 14.750.000 13.19%
2021 16.247.000 9.21%
2022 17.049.000 4.7%
2023 26.039.000 34.53%
2024 26.888.000 3.16%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Neogen Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 5.300.000 100%
1997 6.400.000 17.19%
1998 7.600.000 15.79%
1999 8.500.000 10.59%
2000 8.689.000 2.18%
2001 11.635.000 25.32%
2002 13.149.000 11.51%
2003 15.026.000 12.49%
2004 17.074.000 11.99%
2005 19.105.000 10.63%
2006 21.973.000 13.05%
2007 27.764.000 20.86%
2008 31.575.000 12.07%
2009 11.484.000 -174.95%
2010 13.488.000 14.86%
2011 15.112.000 10.75%
2012 17.024.000 11.23%
2013 20.216.000 15.79%
2014 24.449.000 17.31%
2015 25.233.000 3.11%
2016 29.189.000 13.55%
2017 34.214.000 14.69%
2018 38.294.000 10.65%
2019 40.791.000 6.12%
2020 44.331.000 7.99%
2021 51.197.000 13.41%
2022 82.742.000 38.12%
2023 201.179.000 58.87%
2024 180.484.000 -11.47%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Neogen Corporation EBITDA
Year EBITDA Growth
1988 -400.000
1989 100.000 500%
1990 -1.700.000 105.88%
1991 -1.600.000 -6.25%
1992 -900.000 -77.78%
1993 -600.000 -50%
1994 1.300.000 146.15%
1995 900.000 -44.44%
1996 1.500.000 40%
1997 1.400.000 -7.14%
1998 1.400.000 0%
1999 3.800.000 63.16%
2000 1.937.000 -96.18%
2001 5.306.000 63.49%
2002 6.240.000 14.97%
2003 7.531.000 17.14%
2004 8.799.000 14.41%
2005 10.249.000 14.15%
2006 14.213.000 27.89%
2007 16.331.000 12.97%
2008 21.498.000 24.03%
2009 19.352.000 -11.09%
2010 26.437.000 26.8%
2011 41.855.000 36.84%
2012 33.739.000 -24.06%
2013 40.706.000 17.12%
2014 43.391.000 6.19%
2015 53.118.000 18.31%
2016 56.386.000 5.8%
2017 64.945.000 13.18%
2018 70.194.000 7.48%
2019 68.094.000 -3.08%
2020 67.523.000 -0.85%
2021 74.169.000 8.96%
2022 58.618.000 -26.53%
2023 37.515.000 -56.25%
2024 191.476.000 80.41%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Neogen Corporation Gross Profit
Year Gross Profit Growth
1988 2.100.000
1989 3.200.000 34.38%
1990 2.900.000 -10.34%
1991 2.900.000 0%
1992 3.200.000 9.38%
1993 4.100.000 21.95%
1994 6.400.000 35.94%
1995 7.000.000 8.57%
1996 7.500.000 6.67%
1997 9.700.000 22.68%
1998 11.300.000 14.16%
1999 13.600.000 16.91%
2000 13.598.000 -0.01%
2001 17.738.000 23.34%
2002 20.901.000 15.13%
2003 24.725.000 15.47%
2004 27.509.000 10.12%
2005 30.603.000 10.11%
2006 37.006.000 17.3%
2007 44.563.000 16.96%
2008 53.233.000 16.29%
2009 59.433.000 10.43%
2010 72.975.000 18.56%
2011 87.792.000 16.88%
2012 92.425.000 5.01%
2013 109.494.000 15.59%
2014 122.598.000 10.69%
2015 139.685.000 12.23%
2016 153.064.000 8.74%
2017 171.968.000 10.99%
2018 190.252.000 9.61%
2019 191.920.000 0.87%
2020 196.279.000 2.22%
2021 215.056.000 8.73%
2022 243.013.000 11.5%
2023 405.955.000 40.14%
2024 467.044.000 13.08%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Neogen Corporation Net Profit
Year Net Profit Growth
1988 -1.100.000
1989 -500.000 -120%
1990 -200.000 -150%
1991 -800.000 75%
1992 -800.000 0%
1993 -500.000 -60%
1994 900.000 155.56%
1995 700.000 -28.57%
1996 -200.000 450%
1997 1.800.000 111.11%
1998 2.200.000 18.18%
1999 2.300.000 4.35%
2000 3.074.000 25.18%
2001 3.170.000 3.03%
2002 3.945.000 19.65%
2003 4.787.000 17.59%
2004 5.099.000 6.12%
2005 5.916.000 13.81%
2006 7.941.000 25.5%
2007 9.125.000 12.98%
2008 12.098.000 24.57%
2009 13.874.000 12.8%
2010 17.521.000 20.82%
2011 22.839.000 23.28%
2012 22.513.000 -1.45%
2013 27.190.000 17.2%
2014 28.158.000 3.44%
2015 33.526.000 16.01%
2016 36.564.000 8.31%
2017 43.793.000 16.51%
2018 63.145.000 30.65%
2019 60.176.000 -4.93%
2020 59.475.000 -1.18%
2021 60.882.000 2.31%
2022 48.307.000 -26.03%
2023 -22.870.000 311.22%
2024 6.012.000 480.41%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Neogen Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Neogen Corporation Free Cashflow
Year Free Cashflow Growth
1992 -900.000
1993 -600.000 -50%
1994 1.500.000 140%
1995 -1.100.000 236.36%
1996 -200.000 -450%
1997 1.600.000 112.5%
1998 900.000 -77.78%
1999 2.800.000 67.86%
2000 3.756.000 25.45%
2001 1.397.000 -168.86%
2002 1.679.000 16.8%
2003 4.240.000 60.4%
2004 -2.062.000 305.63%
2005 4.034.000 151.12%
2006 9.621.000 58.07%
2007 5.454.000 -76.4%
2008 5.402.000 -0.96%
2009 8.149.000 33.71%
2010 22.557.000 63.87%
2011 21.047.000 -7.17%
2012 9.864.000 -113.37%
2013 17.664.000 44.16%
2014 10.125.000 -74.46%
2015 34.173.000 70.37%
2016 21.109.000 -61.89%
2017 45.696.000 53.81%
2018 48.185.000 5.17%
2019 49.181.000 2.03%
2020 61.826.000 20.45%
2021 54.377.000 -13.7%
2022 43.609.000 -24.69%
2023 -24.729.000 276.35%
2024 -7.621.000 -224.48%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Neogen Corporation Operating Cashflow
Year Operating Cashflow Growth
1992 -700.000
1993 -400.000 -75%
1994 1.700.000 123.53%
1995 -500.000 440%
1996 900.000 155.56%
1997 2.300.000 60.87%
1998 1.500.000 -53.33%
1999 3.700.000 59.46%
2000 4.676.000 20.87%
2001 2.496.000 -87.34%
2002 3.396.000 26.5%
2003 6.701.000 49.32%
2004 2.981.000 -124.79%
2005 6.722.000 55.65%
2006 12.313.000 45.41%
2007 10.158.000 -21.21%
2008 7.873.000 -29.02%
2009 10.985.000 28.33%
2010 27.988.000 60.75%
2011 28.843.000 2.96%
2012 22.277.000 -29.47%
2013 26.561.000 16.13%
2014 21.668.000 -22.58%
2015 43.792.000 50.52%
2016 35.331.000 -23.95%
2017 60.274.000 41.38%
2018 69.131.000 12.81%
2019 63.842.000 -8.28%
2020 85.878.000 25.66%
2021 81.089.000 -5.91%
2022 68.038.000 -19.18%
2023 41.028.000 -65.83%
2024 23.009.000 -78.31%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Neogen Corporation Capital Expenditure
Year Capital Expenditure Growth
1992 200.000
1993 200.000 0%
1994 200.000 0%
1995 600.000 66.67%
1996 1.100.000 45.45%
1997 700.000 -57.14%
1998 600.000 -16.67%
1999 900.000 33.33%
2000 920.000 2.17%
2001 1.099.000 16.29%
2002 1.717.000 35.99%
2003 2.461.000 30.23%
2004 5.043.000 51.2%
2005 2.688.000 -87.61%
2006 2.692.000 0.15%
2007 4.704.000 42.77%
2008 2.471.000 -90.37%
2009 2.836.000 12.87%
2010 5.431.000 47.78%
2011 7.796.000 30.34%
2012 12.413.000 37.19%
2013 8.897.000 -39.52%
2014 11.543.000 22.92%
2015 9.619.000 -20%
2016 14.222.000 32.37%
2017 14.578.000 2.44%
2018 20.946.000 30.4%
2019 14.661.000 -42.87%
2020 24.052.000 39.04%
2021 26.712.000 9.96%
2022 24.429.000 -9.35%
2023 65.757.000 62.85%
2024 30.630.000 -114.68%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Neogen Corporation Equity
Year Equity Growth
1988 -4.100.000
1989 -4.500.000 8.89%
1990 7.900.000 156.96%
1991 7.100.000 -11.27%
1992 6.400.000 -10.94%
1993 6.100.000 -4.92%
1994 7.700.000 20.78%
1995 8.800.000 12.5%
1996 8.900.000 1.12%
1997 21.000.000 57.62%
1998 23.600.000 11.02%
1999 23.800.000 0.84%
2000 25.804.000 7.77%
2001 29.337.000 12.04%
2002 35.546.000 17.47%
2003 41.402.000 14.14%
2004 47.842.000 13.46%
2005 54.835.000 12.75%
2006 64.548.000 15.05%
2007 91.945.000 29.8%
2008 111.248.000 17.35%
2009 128.679.000 13.55%
2010 153.053.000 15.93%
2011 188.645.000 18.87%
2012 219.054.000 13.88%
2013 258.287.000 15.19%
2014 306.300.000 15.68%
2015 350.963.000 12.73%
2016 404.161.000 13.16%
2017 471.757.000 14.33%
2018 560.175.000 15.78%
2019 637.899.000 12.18%
2020 725.177.000 12.04%
2021 840.377.000 13.71%
2022 887.374.000 5.3%
2023 3.134.217.000 71.69%
2024 3.146.175.000 0.38%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Neogen Corporation Assets
Year Assets Growth
1988 5.200.000
1989 4.600.000 -13.04%
1990 9.400.000 51.06%
1991 8.500.000 -10.59%
1992 7.600.000 -11.84%
1993 7.300.000 -4.11%
1994 9.100.000 19.78%
1995 11.500.000 20.87%
1996 11.500.000 0%
1997 23.100.000 50.22%
1998 25.400.000 9.06%
1999 26.100.000 2.68%
2000 29.528.000 11.61%
2001 33.022.000 10.58%
2002 39.904.000 17.25%
2003 48.036.000 16.93%
2004 59.975.000 19.91%
2005 63.884.000 6.12%
2006 88.290.000 27.64%
2007 105.284.000 16.14%
2008 126.357.000 16.68%
2009 142.176.000 11.13%
2010 180.233.000 21.12%
2011 219.662.000 17.95%
2012 251.600.000 12.69%
2013 289.251.000 13.02%
2014 345.301.000 16.23%
2015 392.181.000 11.95%
2016 451.715.000 13.18%
2017 528.409.000 14.51%
2018 618.009.000 14.5%
2019 695.740.000 11.17%
2020 797.182.000 12.73%
2021 920.192.000 13.37%
2022 992.929.000 7.33%
2023 4.554.432.000 78.2%
2024 4.561.105.000 0.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Neogen Corporation Liabilities
Year Liabilities Growth
1988 9.300.000
1989 9.100.000 -2.2%
1990 1.500.000 -506.67%
1991 1.400.000 -7.14%
1992 1.200.000 -16.67%
1993 1.200.000 0%
1994 1.400.000 14.29%
1995 2.700.000 48.15%
1996 2.600.000 -3.85%
1997 2.100.000 -23.81%
1998 1.800.000 -16.67%
1999 2.300.000 21.74%
2000 3.724.000 38.24%
2001 3.685.000 -1.06%
2002 4.358.000 15.44%
2003 6.634.000 34.31%
2004 12.133.000 45.32%
2005 9.049.000 -34.08%
2006 23.742.000 61.89%
2007 13.339.000 -77.99%
2008 15.109.000 11.71%
2009 13.497.000 -11.94%
2010 27.180.000 50.34%
2011 30.684.000 11.42%
2012 32.546.000 5.72%
2013 30.964.000 -5.11%
2014 39.001.000 20.61%
2015 41.218.000 5.38%
2016 47.554.000 13.32%
2017 56.652.000 16.06%
2018 57.834.000 2.04%
2019 57.841.000 0.01%
2020 72.005.000 19.67%
2021 79.815.000 9.79%
2022 105.555.000 24.39%
2023 1.420.215.000 92.57%
2024 1.414.930.000 -0.37%

Neogen Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
337165.27x
Price To Sales Ratio
4.32x
POCF Ratio
31417.19
PFCF Ratio
72.02
Price to Book Ratio
1261.65
EV to Sales
5.06
EV Over EBITDA
45.84
EV to Operating CashFlow
36.79
EV to FreeCashFlow
84.38
Earnings Yield
0
FreeCashFlow Yield
0.01
Market Cap
3,97 Bil.
Enterprise Value
4,65 Bil.
Graham Number
0
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
0
Income Quality
10.73
ROE
0
Return On Assets
0
Return On Capital Employed
0.01
Net Income per EBT
3.56
EBT Per Ebit
0.07
Ebit per Revenue
0.05
Effective Tax Rate
-2.56

Margins

Sales, General, & Administrative to Revenue
0.21
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.51
Operating Profit Margin
0.05
Pretax Profit Margin
0
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
-0.56
Capex to Revenue
-0.08
Capex to Depreciation
-0.62
Return on Invested Capital
0.04
Return on Tangible Assets
0.01
Days Sales Outstanding
59.79
Days Payables Outstanding
90.19
Days of Inventory on Hand
129.06
Receivables Turnover
6.1
Payables Turnover
4.05
Inventory Turnover
2.83
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,01
Tangible Book Value per Share
-0
Shareholders Equity per Share
0.01
Interest Debt per Share
0
Debt to Equity
0.29
Debt to Assets
0.19
Net Debt to EBITDA
6.71
Current Ratio
3.54
Tangible Asset Value
-0,56 Bil.
Net Current Asset Value
-0,83 Bil.
Invested Capital
0.29
Working Capital
0,45 Bil.
Intangibles to Total Assets
0.8
Average Receivables
0,14 Bil.
Average Payables
0,10 Bil.
Average Inventory
150610500
Debt to Market Cap
0.23

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Neogen Corporation Dividends
Year Dividends Growth

Neogen Corporation Profile

About Neogen Corporation

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

CEO
Mr. John Edward Adent
Employee
2.640
Address
620 Lesher Place
Lansing, 48912

Neogen Corporation Executives & BODs

Neogen Corporation Executives & BODs
# Name Age
1 Ms. Amy M. Rocklin Ph.D.
Chief Legal & Compliance Officer and Corporate Secretary
70
2 Sarah Demey
Administrative Manager
70
3 Mr. John Edward Adent
President, Chief Executive Officer & Director
70
4 Dr. Robert S. Donofrio Ph.D.
Vice President & Chief Scientific Officer
70
5 Ms. Julie A. Mann
Vice President & Chief Human Resources Officer
70
6 Mr. Bill Waelke
Head of Investor Relations
70
7 Mr. Douglas E. Jones
Chief Operating Officer & Vice President
70
8 Mr. David H. Naemura
Chief Financial Officer
70

Neogen Corporation Competitors